Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Baumgart

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Der Internist|March 31, 2017
[Fundamentals of the microbiome]P R Steinhagen, D C Baumgart
Der Internist|May 26, 1998
[18-year-old patient with hypercalcemia, hypophosphatemia, nephrocalcinosis and normal iPTH values. Primary hyperparathyroidism]D C Baumgart, M Ventz, W Wermke
Alimentary Pharmacology & Therapeutics|September 9, 2004
Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanismsA U Dignass, D C Baumgart, A Sturm
Alimentary Pharmacology & Therapeutics|May 21, 2003
Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel diseaseD C Baumgart, B Wiedenmann, A U Dignass
Zeitschrift Fur Gastroenterologie|October 17, 2003
[Biologic therapy of inflammatory bowel disease]D C Baumgart, B Wiedenmann, A U Dignass
International Journal of Molecular Medicine|December 16, 1998
Mechanisms of immune cell-mediated tissue injury in inflammatory bowel disease (Review)D C Baumgart, L D McVay, S R Carding
Gastroenterology|December 13, 2000
Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased statesG W Telega, D C Baumgart, S R Carding
Alimentary Pharmacology & Therapeutics|April 3, 2016
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice--a nationwide consecutive German cohort studyD C Baumgart, B Bokemeyer, A Drabik, et al.
Clinical and Experimental Immunology|January 24, 2009
Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferationS Thomas, I Przesdzing, D Metzke, et al.
Advances in Clinical Chemistry|October 9, 2016
Autoimmunity in Crohn's Disease-A Putative Stratification Factor of the Clinical PhenotypeD Roggenbuck, D Reinhold, D C Baumgart, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Der Internist|March 31, 2017
[Fundamentals of the microbiome]P R Steinhagen, D C Baumgart
Der Internist|May 26, 1998
[18-year-old patient with hypercalcemia, hypophosphatemia, nephrocalcinosis and normal iPTH values. Primary hyperparathyroidism]D C Baumgart, M Ventz, W Wermke
Alimentary Pharmacology & Therapeutics|September 9, 2004
Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanismsA U Dignass, D C Baumgart, A Sturm
Alimentary Pharmacology & Therapeutics|May 21, 2003
Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel diseaseD C Baumgart, B Wiedenmann, A U Dignass
Zeitschrift Fur Gastroenterologie|October 17, 2003
[Biologic therapy of inflammatory bowel disease]D C Baumgart, B Wiedenmann, A U Dignass
International Journal of Molecular Medicine|December 16, 1998
Mechanisms of immune cell-mediated tissue injury in inflammatory bowel disease (Review)D C Baumgart, L D McVay, S R Carding
Gastroenterology|December 13, 2000
Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased statesG W Telega, D C Baumgart, S R Carding
Alimentary Pharmacology & Therapeutics|April 3, 2016
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice--a nationwide consecutive German cohort studyD C Baumgart, B Bokemeyer, A Drabik, et al.
Clinical and Experimental Immunology|January 24, 2009
Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferationS Thomas, I Przesdzing, D Metzke, et al.
Advances in Clinical Chemistry|October 9, 2016
Autoimmunity in Crohn's Disease-A Putative Stratification Factor of the Clinical PhenotypeD Roggenbuck, D Reinhold, D C Baumgart, et al.
Pageof 3